YOUR FOUNTAIN OF YOUTH
LIVE

Serial Number

79324818

Owner

KWALATA TRADING LIMITED

Attorney

Julianne Abelman

Filing Date

May 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

YOUR FOUNTAIN OF YOUTH Trademark

Serial Number: 79324818 • Registration: 7082461

YOUR FOUNTAIN OF YOUTH is a trademark filed by KWALATA TRADING LIMITED on May 25, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

KWALATA TRADING LIMITED (7 trademarks)

P.O. BOX 22454
NICOSIA 1522 , CY

Entity Type: 03

Trademark Details

Filing Date

May 25, 2021

Registration Date

June 20, 2023

Published for Opposition

April 4, 2023

Goods & Services

Services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components being a novel human cell population; services in the medical field, namely, medical services performed in a laboratory for medical research companies, the foregoing consisting of selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the body

Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for research, other experiments of minor health disorders to prevent them from becoming severe health disorders

Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, end-stage heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progress

Research and development in the field of blood, blood products being comprised of a synergistic cell population of stem cells including angiogenic cell precursors, and blood testing; scientific research services in the field of blood and stem cells

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 24, 2026 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 26, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 26, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2023 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 20, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 20, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 20, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Apr 5, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 15, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 15, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2023 CNEA
REFUSAL PROCESSED BY IB
Feb 7, 2023 RFNT
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 31, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 31, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 31, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2022 TROA
ASSIGNED TO EXAMINER
Oct 20, 2022 DOCK
REFUSAL PROCESSED BY IB
Jul 5, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 15, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 15, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
May 16, 2022 CNRT
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 10, 2022 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
May 2, 2022 CRCV
ASSIGNED TO EXAMINER
Feb 7, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 4, 2021 REPR